FDA Reports of Alopecia as an Adverse Event to Isotretinoin.

MLA

Tkachenko, Elizabeth, et al. “FDA Reports of Alopecia as an Adverse Event to Isotretinoin.” Journal of Cutaneous Medicine & Surgery, vol. 23, no. 4, July 2019, pp. 451–52. EBSCOhost, https://doi.org/10.1177/1203475419838553.

APA

Tkachenko, E., Singer, S. B., Sharma, P., Barbieri, J., & Mostaghimi, A. (2019). FDA Reports of Alopecia as an Adverse Event to Isotretinoin. Journal of Cutaneous Medicine & Surgery, 23(4), 451–452. https://doi.org/10.1177/1203475419838553

Chicago

Tkachenko, Elizabeth, Sean B. Singer, Priyank Sharma, John Barbieri, and Arash Mostaghimi. 2019. “FDA Reports of Alopecia as an Adverse Event to Isotretinoin.” Journal of Cutaneous Medicine & Surgery 23 (4): 451–52. doi:10.1177/1203475419838553.